Background illustration for clinical trials search

Triple Negative Breast Cancer Clinical Trials

Browse 2,256 triple negative breast cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Targeted Palliative Care Intervention for Patients With Metastatic Breast Cancer

for
Metastatic Breast Cancer
Location: Boston MA, Philadelphia PA, Durham NC
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18+

Code: NCT06795529

Recruiting

EXoPERT EMERALD Clinical Study

for
Breast Cancer, Colon Cancer, Pancreatic Cancer, Ovarian Cancer,
Location: The Bronx NY, Wappingers Falls NY, Albany NY,
Sponsor: EXoPERT

Sex: All

Age: 45+

Code: NCT07186296

Recruiting

Adapting The Fear Of Recurrence Therapy (FORT) for Parents and Establishing Acceptability and Feasibility

for
Cancer, Parent, Fear of Cancer Recurrence, CBT,
Location: Ottawa
Sponsor: University of Ottawa

Sex: All

Age: 18+

Code: NCT06872840

Recruiting

Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention

for
Cancer, Fatigue, Brain Tumor Adult
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18 - 39

Code: NCT07186556

Recruiting

Clinical Study To Further Evaluate The Efficacy Of Dabrafenib Plus Trametinib In Patients With Rare BRAF V600E Mutation-Positive Unresectable or Metastatic Solid Tumors

for
Rare Unresectable or Metastatic BRAF V600E Mutation-positive Solid Tumors,
Location: Washington D.C. DC, Durham NC, Cincinnati OH,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 1 - 70+

Code: NCT05868629

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Novel Cavity Marking Technique in Breast Cancer Patients Undergoing Breast Conservation Surgery With Oncoplastic Reconstruction for the Delivery of Adjuvant Radiotherapy and Accuracy of Recommended Re-excisions

for
Ductal Carcinoma in Situ, Breast Cancer
Location: Gainesville FL
Sponsor: University of Florida

Sex: All

Age: 18+

Code: NCT06903468

Recruiting

Impact of Project ECHO on Improving the Quality of Palliative Care in Patients With Advanced Cancer and Their Caregivers in Underserved Areas of Kenya, Nigeria, Ghana, South Africa, India, and Ethiopia

for
Advanced Malignant Solid Neoplasm,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 0+

Code: NCT04984551

Phase 2, Recruiting

Molecular Residual Disease Assessment in a Representative Diverse Population of Patients With Early-stage Breast Cancer

for
Breast Cancer, Lymph Node Metastasis
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT07025785

Recruiting

A Study of DS5361b in Participants With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Providence RI, Fairfax VA, Sarasota FL, Irving TX,
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT07182591

Phase 1, Recruiting

Different Types of Massage Therapy to Reduce Anxiety During Chemotherapy Infusion in Patients With Cancer

for
Hematopoietic and Lymphatic System Neoplasm,
Location: Irvine CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT07184294

Recruiting

Precise Oncology Interventions in Nutrition and Training (OnPoint)

for
Breast Cancer, Prostate Cancer, Colorectal Cancer, Lymphoma
Location: Miami FL
Sponsor: University of Miami

Sex: All

Age: 18+

Code: NCT06534918

Recruiting

Improving Comprehensive Care of Cancer Patients

for
Breast Cancer, Gastrointestinal Cancer, Hematologic Cancer
Location: Houston TX
Sponsor: Baylor College of Medicine

Sex: All

Age: 18+

Code: NCT05323409

Recruiting

Simulation-Free Celiac Plexus Pain Ablation Using Stereotactic Body Radiotherapy in Patients With Cancer-Related Celiac Pain

for
Advanced Cancer, Pancreatic Cancer
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT07636382

Recruiting

FOCUS ON US: Adapting the FOCUS Program for Sexual and Gender Minority (SGM) Cancer Patients and Caregivers

for
Cancer Support, Oncology Patients, Caregivers
Location: Rochester NY, Detroit MI
Sponsor: Charles Kamen

Sex: All

Age: 18 - 70+

Code: NCT06800053

Recruiting

Behavioral Pain Intervention for Older Cancer Patients

for
Breast Cancer
Location: Durham NC
Sponsor: Weill Medical College of Cornell University

Sex: Female

Age: 55+

Code: NCT07300995

Recruiting

A Study of Disappearing Markers for Daily Radiation Treatment Delivery for Breast Cancer Patients.

for
Ductal Carcinoma in Situ, Stage I Breast Cancer,
Location: Detroit MI
Sponsor: Barbara Ann Karmanos Cancer Institute

Sex: Female

Age: 18+

Code: NCT07095114

Recruiting

An Open-Label Study to Evaluate PF-07994525 in Participants With Advanced Cancers

for
Advanced Malignancies, Advanced Cancer
Location: North Haven CT, New Haven CT, Deerfield Beach FL,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07426757

Phase 1, Recruiting

ORION-1: Study of AVZO-023 as a Single Agent and in Combination With AVZO-021, and/or Endocrine Therapy in Advanced Solid Tumors

for
HR+/HER2- Breast Cancer, HR+, HER2-, Advanced Breast Cancer
Location: New York NY, Sarasota FL, Houston TX, New Haven CT,
Sponsor: Avenzo Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06998407

Phase 1, Phase 2, Recruiting

Study of GS-5319 Given Alone or in Combination in Adults With Solid Tumors

for
Advanced Solid Tumor
Location: Boston MA, New Brunswick NJ, Fairfax VA, San Antonio TX
Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT07128303

Phase 1, Recruiting

SLV-324 Treatment of Metastatic Solid Tumors

for
Metastatic Solid Tumors
Location: Philadelphia PA, Cleveland OH, St Louis MO, Houston TX,
Sponsor: Solve Therapeutics

Sex: All

Age: 18+

Code: NCT07108114

Phase 1, Recruiting

What is triple negative breast cancer?

Triple negative breast cancer, or TNBC, is breast cancer whose cells test negative for estrogen receptors, progesterone receptors, and excess HER2 protein, so hormone therapy and HER2 targeted drugs do not work against it. It tends to grow faster and is more common in women who have not gone through menopause, in Black women, and in people with an inherited BRCA1 mutation, so genetic testing is recommended for everyone diagnosed. In US data, five year relative survival is about 92 percent when it is found while localized, 67 percent with regional spread, and 15 percent once it has reached distant organs. Standard treatment for early stage disease is chemotherapy combined with immunotherapy before surgery, followed by more treatment after; metastatic disease is treated with chemotherapy, immunotherapy for PD-L1 positive tumors, and antibody drug conjugates. Other breast cancers are covered on our breast cancer clinical trials page.

Types of triple negative breast cancer clinical trials

Who can participate in triple negative breast cancer clinical trials?

Is triple negative breast cancer hereditary?

Stages of triple negative breast cancer, and why they matter for trials

How to enroll in a triple negative breast cancer clinical trial